1. Home
  2. GSHD vs WVE Comparison

GSHD vs WVE Comparison

Compare GSHD & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Goosehead Insurance Inc.

GSHD

Goosehead Insurance Inc.

HOLD

Current Price

$57.31

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.85

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSHD
WVE
Founded
2003
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
GSHD
WVE
Price
$57.31
$5.85
Analyst Decision
Buy
Strong Buy
Analyst Count
12
16
Target Price
$72.50
$29.81
AVG Volume (30 Days)
588.9K
2.6M
Earning Date
04-22-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.04
N/A
Revenue
$365,304,000.00
$3,704,000.00
Revenue This Year
$16.40
N/A
Revenue Next Year
$18.53
$85.67
P/E Ratio
$51.83
N/A
Revenue Growth
16.15
149.43
52 Week Low
$33.68
$5.02
52 Week High
$93.91
$21.73

Technical Indicators

Market Signals
Indicator
GSHD
WVE
Relative Strength Index (RSI) 62.36 45.35
Support Level $40.71 $5.49
Resistance Level $77.70 $6.48
Average True Range (ATR) 3.95 0.27
MACD -0.21 -0.01
Stochastic Oscillator 88.91 32.81

Price Performance

Historical Comparison
GSHD
WVE

About GSHD Goosehead Insurance Inc.

Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: